European Psychiatry (Mar 2023)
Suicidality and self-injury behaviours due to the use of Novel Psychoactive Substances (NPS)
Abstract
Abstract Over the past twenty years a large number of new psychoactive substances (NPS) have entered and modified the recreational drug scene. Their intake has been associated with health-related risks, especially so for vulnerable populations such as people with severe mental illness, who might be at higher risk of suicidality or self-injurious behavior. The consumption and frequent poly-consumption of NPS result in death, suicide, serious self-injury behaviours as well as adverse effects on medical and mental health. Hence, the talk will deal with current data on suicidality and self-injury behaviours due to the use of NPS, particularly considering the suicide and self-injury risk due to the NPS intake among vulnerable people with preexisting severe mental illness. Disclosure of Interest None Declared